Canine Infectious Hepatitis (CIH) is a highly contagious viral disease that affects dogs, primarily those belonging to the Canidae family. It is caused by the Canine Adenovirus Type 1 (CAV-1), which primarily targets the liver, kidneys, and eyes, leading to various symptoms and potential organ damage.
CIH is primarily transmitted through direct contact with infected bodily secretions such as urine, feces, saliva, and nasal discharge. It can also spread indirectly through contaminated objects or surfaces. Once a dog is exposed to the virus, it enters the bloodstream and is carried to various organs, where it causes inflammation and cell damage.
The symptoms of CIH vary depending on the severity of the infection but may include fever, loss of appetite, lethargy, abdominal pain, and vomiting. In more severe cases, signs of liver dysfunction such as jaundice and coagulation abnormalities may also be observed.
Vaccination plays a crucial role in preventing Canine Infectious Hepatitis. Regular vaccinations can provide immunity against the virus, reducing the risk of infection. Treatment for CIH mainly involves supportive care, which includes fluid therapy, medication to control symptoms, and monitoring for potential complications.
While CIH primarily affects dogs, it is important to note that there is no evidence to suggest that it can be transmitted from dogs to humans or other non-canine species. Regular veterinary check-ups and adherence to vaccination schedules are important preventive measures to ensure the health and well-being of dogs.
